Biosante Pharmaceuticals, Inc.

Lincolnshire, IL 60069

Market Performance

NASDAQ: BPAX
52 Week Low $N/A

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $242K
First Award Date 08/01/03
Most Recent Award Date 07/11/08

Key Personnel

Last Name Name Awards Contact
Morcol Tulin Morcol 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 07/11/08 - 06/30/10

DESCRIPTION (provided by applicant): Chronic infections with hepatitis B or hepatitis C viruses are global health problems affecting hundreds of millions of people worldwide. Various commercial products of interferon alpha are approved in the United States for the treatment of adults with hepatitis B and hepatitis C. However, therapy with interf...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/03 - 07/31/05

DESCRIPTION (provided by applicant): Parenteral administration of insulin via the subcutaneous route is the only commercially available therapy to treat insulin-dependent diabetes mellitus. Multiple daily injections are required to manage and maintain blood glucose control due to its relatively short duration of action (4 to 8 hours). Oral insul...